|Articles|May 11, 2022
- Pharmaceutical Executive-05-01-2022
- Volume 42
- Issue 5
Pharmaceutical Executive, May 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive May 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 4 years ago
Restoring Hope in Mental Illness Is a Collective Missionover 4 years ago
Upward Mobility: Optimizing Your Pharma T-Profileover 4 years ago
Breadth, Depth, and Enterpriseover 4 years ago
Rising to the Taskover 4 years ago
Lessons Learnedover 4 years ago
Persistence Pays Offover 4 years ago
Authenticity in Actionover 4 years ago
Challenging Assumptionsover 4 years ago
Steady at the ControlsAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Artisan Partners’ Director Calls for Novartis Board Shake-Up
2
The Agentic AI Revolution in Biopharma
3
340B Under Pressure: Inside Pharma's Push for Greater Clarity
4
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
5

